![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
Bausch & Lomb, Inc. |
---|---|
Information provided by: | Bausch & Lomb, Inc. |
ClinicalTrials.gov Identifier: | NCT00769886 |
The purpose of this study is to establish the safety and efficacy of ketotifen/naphazoline ophthalmic solution compared to vehicle and its individual components in alleviating the signs and symptoms of conjunctival allergen challenge (CAC)-induced allergic conjunctivitis.
Condition | Intervention | Phase |
---|---|---|
Allergic Conjunctivitis |
Drug: Ketotifen/naphazoline Drug: Ketotifen/naphazoline & Vehicle Drug: Ketotifen/naphazoline and Naphazoline Drug: Ketotifen/naphazoline and Ketotifen Drug: Ketotifen and Ketotifen/naphazoline Drug: Ketotifen and vehicle Drug: Ketotifen and Naphazoline Drug: Ketotifen Drug: Naphazoline and Ketotifen/naphazoline Drug: Naphazoline and Vehicle Drug: Naphazoline Drug: Naphazoline and Ketotifen Drug: Vehicle and Ketotifen/naphazoline Drug: Vehicle Drug: Vehicle and Naphazoline Drug: Vehicle and Ketotifen |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Investigator), Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Estimated Enrollment: | 144 |
Study Start Date: | October 2008 |
Estimated Study Completion Date: | March 2009 |
Estimated Primary Completion Date: | January 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Active Comparator
Right eye - Ketotifen/naphazoline, Left eye - Ketotifen/naphazoline
|
Drug: Ketotifen/naphazoline
One drop in each eye at visit 3 and visit 4.
|
2: Active Comparator
Right eye - Ketotifen/naphazoline, Left eye - Vehicle
|
Drug: Ketotifen/naphazoline & Vehicle
One drop of Ketotifen/naphazoline in right eye; one drop of vehicle in left eye at visit 3 and visit 4.
|
3: Active Comparator
Right eye - Ketototifen/naphazoline, Left eye - Naphazoline
|
Drug: Ketotifen/naphazoline and Naphazoline
One drop of Ketotifen/naphazoline in the right eye; one drop of naphazoline in the left eye at visit 3 and visit 4.
|
4: Active Comparator
Right eye - Ketotifen/naphazoline, Left eye - Ketotifen
|
Drug: Ketotifen/naphazoline and Ketotifen
One drop of Ketotifen/naphazoline in the right eye; one drop of ketotifen in the left eye at visit 3 and visit 4.
|
5: Active Comparator
Right eye - Ketotifen, Left eye - Ketotifen/naphazoline
|
Drug: Ketotifen and Ketotifen/naphazoline
One drop of ketotifen in the right eye; one drop of ketotifen/naphazoline in the left eye at visit 3 and visit 4.
|
6: Active Comparator
Right eye - Ketotifen, Left eye - Vehicle
|
Drug: Ketotifen and vehicle
One drop of Ketotifen in the right eye, one drop of vehicle in the left eye at visit 3 and visit 4.
|
7: Active Comparator
Right eye - Ketotifen, Left eye - Naphazoline
|
Drug: Ketotifen and Naphazoline
One drop of ketotifen in the right eye; one drop of naphazoline in the left eye at visit 3 and visit 4.
|
8: Active Comparator
Right eye - Ketotifen, Left eye - Ketotifen
|
Drug: Ketotifen
One drop of ketotifen in each eye at visit 3 and visit 4.
|
9: Active Comparator
Right eye - Naphazoline, Left eye - Ketotifen/naphazoline
|
Drug: Naphazoline and Ketotifen/naphazoline
One drop of naphazoline in the right eye; one drop of ketotifen/naphazoline in the left eye at visit 3 and visit 4.
|
10: Active Comparator
Right eye - Naphazoline, Left eye - Vehicle
|
Drug: Naphazoline and Vehicle
One drop of naphazoline in the right eye; one drop of vehicle in the left eye at visit 3 and visit 4.
|
11: Active Comparator
Right eye - Naphazoline, Left eye - Naphazoline
|
Drug: Naphazoline
One drop of naphazoline in each eye ay vist 3 and visit 4.
|
12: Active Comparator
Right eye - Naphazoline, Left eye - Ketotifen
|
Drug: Naphazoline and Ketotifen
One drop of naphazoline in right eye; one drop of ketotifen in left eye at visit 3 and visit 4.
|
13: Active Comparator
Right eye - Vehicle, Left eye - Ketotifen/naphazoline
|
Drug: Vehicle and Ketotifen/naphazoline
One drop of vehicle in right eye; one drop of ketotifen/naphazoline in left eye at visit 3 and visit 4.
|
14: Placebo Comparator
Right eye - Vehicle, Left eye - Vehicle
|
Drug: Vehicle
One drop of vehicle in each eye at visit 3 and visit 4.
|
15: Active Comparator
Right eye - Vehicle, Left eye - Naphazoline
|
Drug: Vehicle and Naphazoline
One drop of vehicle in right eye; one drop of naphazoline in left eye at visit 3 and visit 4.
|
16: Active Comparator
Right eye - Vehicle, Left eye - Ketotifen
|
Drug: Vehicle and Ketotifen
One drop of vehicle in right eye; one drop of ketotifen in left eye at visit 3 and visit 4.
|
Ages Eligible for Study: | 6 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Jennifer Lynch | 585-338-6230 | jennifer.lynch@bausch.com |
United States, Massachusetts | |
Ophthalmic Research Consultants, Inc. | Recruiting |
North Andover, Massachusetts, United States, 01845 |
Responsible Party: | Bausch & Lomb, Incorporated ( Marcia De Souza Lima ) |
Study ID Numbers: | 571 |
Study First Received: | October 8, 2008 |
Last Updated: | October 8, 2008 |
ClinicalTrials.gov Identifier: | NCT00769886 |
Health Authority: | United States: Food and Drug Administration |
Pseudoephedrine Conjunctivitis, Allergic Eye Diseases Conjunctivitis Conjunctival Diseases Histamine Naphazoline Oxymetazoline |
Hypersensitivity Ketotifen Phenylephrine Guaifenesin Hypersensitivity, Immediate Histamine phosphate Ephedrine Phenylpropanolamine |
Respiratory System Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Adrenergic Agents Cardiotonic Agents Physiological Effects of Drugs Adrenergic Agonists Nasal Decongestants Therapeutic Uses Vasoconstrictor Agents Appetite Depressants Antipruritics Dermatologic Agents Adrenergic alpha-Agonists Immune System Diseases |
Sympathomimetics Histamine Agents Anti-Allergic Agents Cardiovascular Agents Protective Agents Pharmacologic Actions Anti-Obesity Agents Mydriatics Histamine Antagonists Autonomic Agents Expectorants Histamine H1 Antagonists Peripheral Nervous System Agents Central Nervous System Agents |